| Bridging the gap between the randomised clinical trial world and the real world by combination of population-based registry and electronic health record data: a case study in … RE Kibbelaar, BE Oortgiesen, AM Van Der Wal-Oost, K Boslooper, ... European Journal of Cancer 86, 178-185, 2017 | 39 | 2017 |
| High prevalence of peripheral neuropathy in multiple myeloma patients and the impact of vitamin D levels, a cross-sectional study BE Oortgiesen, JA Kroes, P Scholtens, J Hoogland, ... Supportive Care in Cancer 30, 271-278, 2022 | 20 | 2022 |
| Restoration of renal function in patients with newly diagnosed multiple myeloma is not associated with improved survival: a population-based study JC de Vries, B Oortgiesen, MH Hemmelder, E van Roon, RE Kibbelaar, ... Leukemia & Lymphoma 58 (9), 2101-2109, 2017 | 15 | 2017 |
| The impact of the introduction of bortezomib on dialysis independence in multiple myeloma patients with renal impairment: a nationwide Dutch population-based study BE Oortgiesen, R Azad, MH Hemmelder, RE Kibbelaar, NJGM Veeger, ... haematologica 103 (7), e311, 2018 | 9 | 2018 |
| The role of initial clinical presentation, comorbidity and treatment in multiple myeloma patients on survival: a detailed population-based cohort study BE Oortgiesen, EN van Roon, P Joosten, RE Kibbelaar, H Storm, ... European Journal of Clinical Pharmacology 73, 771-778, 2017 | 9 | 2017 |
| No decrease in fracture risk despite 15 years of treatment evolution for multiple myeloma patients: A Danish nationwide case-control study BE Oortgiesen, JHM Driessen, M Hoogendoorn, RE Kibbelaar, ... Bone 134, 115299, 2020 | 4 | 2020 |
| Effectiveness of a vitamin D regimen in deficient multiple myeloma patients and its effect on peripheral neuropathy BE Oortgiesen, M Dekens, R Stapel, A Alheraky, PK Dannenberg, ... Supportive Care in Cancer 31 (2), 138, 2023 | 3 | 2023 |
| Proton pump inhibitors when using clopidogrel: balance between necessity and disadvantages K van der Elst, B Oortgiesen, W Kruik-Kollöffel, M Hoogendoorn, S Hofma, ... Nederlands Tijdschrift Voor Geneeskunde 163, D3363-D3363, 2019 | 2 | 2019 |
| Overall Survival Patterns in Patients with Multiple Myeloma in the Era of Novel Agents and the Role of Initial Clinical Presentation and Comorbidities: A Population-Based Study B Oortgiesen, EN Van Roon, P Joosten, R Kibbelaar, H Storm, S Hovenga, ... Blood 124 (21), 2136, 2014 | 1 | 2014 |
| Het effect van de CBG-waarschuwing op de trend in SSRI-gebruik in Nederland van 1998 tot 2010 MJ Bijlsma, BE Oortgiesen, RHJ Beernink, J Bos, B Wilffert, E Hak Pharmaceutisch Weekblad 8, A1406, 2014 | 1 | 2014 |
| JW Coebergh, NJGM Veeger, P. Joosten, H. Storm, EN van Roon, M. Hoogendoorn RE Kibbelaar, BE Oortgiesen, AM van der Wal-Oost, K Boslooper Real-world studies of patients with multiple myeloma 86, 29, 2021 | | 2021 |
| S. Hovenga, B. van Rees, G. Woolthuis, N. Veeger, EG de Waal, M. Hoogendoorn BE Oortgiesen, EN van Roon, P Joosten, RE Kibbelaar, H Storm Real-world studies of patients with multiple myeloma 73 (6), 49, 2021 | | 2021 |
| Real-world studies of patients with multiple myeloma: future perspectives on symptom assessment and therapy B Oortgiesen | | 2021 |
| No Decrease in Fracture Risk Despite 15 Years of Treatment Evolution in Multiple Myeloma Patients: A Danish Nationwide Case-Control Study B Oortgiesen, A Driessen, M Hoogendoorn, R Kibbelaar, N Veeger, ... Blood 134, 5503, 2019 | | 2019 |
| Peripheral Neuropathy and Hypovitaminosis D Are Associated in Multiple Myeloma Patients B Oortgiesen, H Kroes, P Scholtens, J Hoogland, ... Blood 134, 5506, 2019 | | 2019 |
| Protonpompremmers bij gebruik van clopidogrel K van der Elst, B Oortgiesen, W Kruik-Kollöffel, M Hoogendoorn NED TIJDSCHR GENEESKD 163, D3363, 2019 | | 2019 |
| The impact of the introduction of bortezomib on dialysis independence in multiple myeloma patients with renal failure: A nationwide dutch population-based study B Oortgiesen, R Azad, M Hemmelder, R Kibbelaar, N Veeger, J de Vries, ... Haematologica 102, 272, 2017 | | 2017 |
